Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis

Zur Kurzanzeige

dc.identifier.uri http://dx.doi.org/10.15488/528
dc.identifier.uri http://www.repo.uni-hannover.de/handle/123456789/552
dc.contributor.author Aumann, Ines
dc.contributor.author Tedja, L.
dc.contributor.author Schulenburg, Johann-Matthias Graf von der
dc.date.accessioned 2016-09-12T13:13:54Z
dc.date.available 2016-09-12T13:13:54Z
dc.date.issued 2016
dc.identifier.citation Aumann, I.; Tedja, L.; Graf von der Schulenburg, Johann-Matthias: Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis. In: Tobacco Induced Diseases 14 (2016), Nr. 1, 31. DOI: http://dx.doi.org/10.1186/s12971-016-0097-4
dc.description.abstract BACKGROUND: Smoking is a major risk factor for chronic obstructive pulmonary disease (COPD). For current smokers who are diagnosed with COPD, their first treatment option is to stop smoking. Motivation is necessary for long-term smoking cessation; therefore, when designing smoking cessation programs, the patients' needs and preferences should be considered. We focused on COPD patients' experiences with existing smoking cessation programs and evaluated their preferences for the improvement of these programs. METHODS: We conducted 18 guideline-based interviews with COPD patients between April and June 2014 in Germany. Each patient with COPD, who was a current or past smoker and had made at least one attempt to quit smoking in the past 5 years, was included in the study. We audiotaped, verbatim transcribed, and evaluated the interviews, using content analysis. RESULTS: The patients had broad and different experiences with pharmaceutical, behavioral, and alternative approaches that supported or negatively influenced the smoking cessation process. Pharmaceuticals were viewed as an expensive alternative with many side effects although they helped to stop cravings for a few moments. Furthermore, the bad structure and impersonal content of the seminars for smoking cessation negatively influenced group cohesion, and therefore degrading the patients' motivation to stop smoking. Alternative methods, such as acupuncture and hypnosis were mostly ineffective in smoking cessation, but in some cases, served as motivational strategies. CONCLUSION: Negative experiences with smoking cessation were explained by the patients' lack of motivation or resolution. Other negative experiences, such as the structure of seminars for smoking cessation and the high price of pharmaceuticals should be addressed through policy changes to increase the patients' motivation to quit smoking. eng
dc.language.iso eng
dc.publisher London : BioMed Central Ltd.
dc.relation.ispartofseries Tobacco Induced Diseases 14 (2016), Nr. 1
dc.rights CC BY 4.0
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.subject Chronic obstructive pulmonary disease eng
dc.subject COPD eng
dc.subject Smoking cessation eng
dc.subject Preferences eng
dc.subject Qualitative interviews eng
dc.subject.ddc 360 | Soziale Probleme, Sozialdienste, Versicherungen ger
dc.subject.ddc 610 | Medizin, Gesundheit ger
dc.title Experiences of COPD patients with existing smoking cessation programs and their preferences for improvement - a qualitative analysis
dc.type article
dc.type Text
dc.relation.issn 1617-9625
dc.relation.doi http://dx.doi.org/10.1186/s12971-016-0097-4
dc.bibliographicCitation.issue 1
dc.bibliographicCitation.volume 14
dc.bibliographicCitation.firstPage 31
dc.description.version publishedVersion
tib.accessRights frei zug�nglich


Die Publikation erscheint in Sammlung(en):

Zur Kurzanzeige

 

Suche im Repositorium


Durchblättern

Mein Nutzer/innenkonto

Nutzungsstatistiken